Literature DB >> 18425727

Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses.

Aoi Son1, Hajime Nakamura, Hiroaki Okuyama, Shin-ichi Oka, Eiji Yoshihara, Wenrui Liu, Yoshiyuki Matsuo, Norihiko Kondo, Hiroshi Masutani, Yasuyuki Ishii, Tomonori Iyoda, Kayo Inaba, Junji Yodoi.   

Abstract

Thioredoxin-binding protein-2 (TBP-2), also known as vitamin D3-up-regulated protein 1 (VDUP1), was identified as an endogenous molecule interacting with thioredoxin (TRX). Here, we show that dendritic cells (DC) derived from TBP-2-deficient mice are defective in the function of T cell activation. To compare TBP-2(-/-) DC function with wild-type (WT) DC, we stimulated DC with lipopolysaccharide (LPS). Although TBP-2(-/-) DC and WT DC expressed comparable levels of MHC class II and costimulatory molecules such as CD40, CD80 and CD86, the IL-12p40, IL-12p70 and IL-6 productions of TBP-2(-/-) DC were attenuated. In a mixed leukocyte reaction (MLR), the concentrations of IL-2, IFN-gamma, IL-4 and IL-10 in the culture supernatant of MLR with TBP-2(-/-) DC were significantly lower than those in the cultures with WT DC. In MLR also, as with LPS stimulation, IL-12p40 and IL-12p70 production from TBP-2(-/-) DC was less than that from WT DC. Proliferation of T cells cultured with TBP-2(-/-) DC was poorer than that with WT DC. In vivo delayed-type hypersensitivity responses in TBP-2(-/-) mice immunized with ovalbumin were significantly reduced compared to WT mice. These results indicate that TBP-2 plays a crucial role in DC to induce T cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425727     DOI: 10.1002/eji.200737939

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

2.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

3.  Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.

Authors:  Hiroshi Masutani; Eiji Yoshihara; So Masaki; Zhe Chen; Junji Yodoi
Journal:  J Clin Biochem Nutr       Date:  2011-10-26       Impact factor: 3.114

4.  Deficiency of thioredoxin binding protein-2 (TBP-2) enhances TGF-β signaling and promotes epithelial to mesenchymal transition.

Authors:  So Masaki; Hiroshi Masutani; Eiji Yoshihara; Junji Yodoi
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 5.  Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Authors:  Eiji Yoshihara; So Masaki; Yoshiyuki Matsuo; Zhe Chen; Hai Tian; Junji Yodoi
Journal:  Front Immunol       Date:  2014-01-09       Impact factor: 7.561

6.  Tumor necrosis factor induces rapid down-regulation of TXNIP in human T cells.

Authors:  Trine B Levring; Martin Kongsbak-Wismann; Anna K O Rode; Fatima A H Al-Jaberi; Daniel V Lopez; Özcan Met; Anders Woetmann; Charlotte M Bonefeld; Niels Ødum; Carsten Geisler
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

Review 7.  Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.

Authors:  Haruka Tsubaki; Ikuo Tooyama; Douglas Gordon Walker
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

8.  Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB.

Authors:  Meng Ding; Qiufang Li; Xiao Tan; Liangyua Zhang; Jun Tan; Lan Zheng
Journal:  Aging (Albany NY)       Date:  2022-08-14       Impact factor: 5.955

9.  TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.

Authors:  Mina Noura; Hidemasa Matsuo; Asami Koyama; Souichi Adachi; Hiroshi Masutani
Journal:  FEBS Open Bio       Date:  2020-06-24       Impact factor: 2.693

10.  A human circulating immune cell landscape in aging and COVID-19.

Authors:  Yingfeng Zheng; Xiuxing Liu; Wenqing Le; Lihui Xie; He Li; Wen Wen; Si Wang; Hongyang Wang; Guang-Hui Liu; Shuai Ma; Zhaohao Huang; Jinguo Ye; Wen Shi; Yanxia Ye; Zunpeng Liu; Moshi Song; Weiqi Zhang; Jing-Dong J Han; Juan Carlos Izpisua Belmonte; Chuanle Xiao; Jing Qu; Wenru Su
Journal:  Protein Cell       Date:  2020-08-11       Impact factor: 14.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.